课题基金 / 基金详情

Imaging Analysis and Molecular Mechanism of angio architectural Change of the Tumor During Multistep Human Hepatocarcinogenesis

Imaging Analysis and Molecular Mechanism of angio architectural Change of the Tumor During Multistep Human Hepatocarcinogenesis
人肝癌多步发生过程中肿瘤血管结构变化的影像学分析及分子机制
批准号:
14570524
负责人:
KUDO Masatoshi
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

KUDO Masatoshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hepatocarcinogenesis is a multistep process, evolving from a hyperplastic nodule to early HCC, through early overt HCC, eventually to advanced overt hypervascular HCC. During this process, changes in intranodular hemodynamics also occu. We clarified in this research that at the initial phase of carcinogenesis, the hemodynamic pattern shows arterial vascularity with hypovascular and portal perfusion(type I). In the next step, both arterial and portal blood supplies decrease(type II). Subsequently, intranodular arterial vascularity increases to isovascularity(type III), and then to hypervascularity(type IV). Another hemodynamic transition occurs from the initial pattern to nodule-in-nodule pattern(arterial vascularity with regional vascular spots in a hypovascular background of portal perfusiai(type V).Fatty metamorphosis is observed frequently in the nodules classified hemodynamically in type II and III. This is attributed to a relative decrease in the blood supply due to a diminished portal supply and immature arterial neovascularization. Decreased arterial and portal supplies are supported by pathological evidence for decreased densities of arterial and portal vessels in early-stage well-differentiated HCCs.It was hypothesized initially and finally demonstrated that an intranodular hemodynamic transition occurs from type I to type II and then from type II to type III, before proceeding from type III to type IV during human hepatocarcinogenesis. This sequence has been confirmed by a 5-year clinical follow-up. Such studies have suggested the possibility of determining the stage of a nodule in the process of malignant transformation based on blood supplies visualized by a combination of tomographic vascular imaging techniques. An accurate detection of intraocular hemodynamics by these means lead to a reliable diagnosis, whether it is benign or malignant
期刊论文(274)
专著(0)
科研奖励(0)
会议论文
Minami Y, Kudo M, Kawasaki T, et al.: "Radiofrequency ablation for sonography undetectable hepatocellular carcinoma in the hepatic dome : value of cntrast-enhanced harmonic sonography associated with artificial pleural effusion."AJR. (in press). (2004)
Minami Y、Kudo M、Kawasaki T 等人:“射频消融治疗肝顶超声检查无法检测到的肝细胞癌:对比增强谐波超声检查与人工胸腔积液相关的价值。”AJR。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Wen YL, Kudo M, Minami Y, et al.: "Detection of tumor vascularity in hepatocellular carcinoma with contrast enhanced Dynamic Flow imaging : comparison with contrast enhanced power Doppler imaging."J Medical Ultrasonics. 30. 141-151 (2003)
Wen YL、Kudo M、Minami Y 等人:“使用对比增强动态流成像检测肝细胞癌中的肿瘤血管分布:与对比增强功率多普勒成像的比较。”J Medical Ultrasonics。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kudo M: "Local ablation therapy for hepatocellular carcinoma : current status and future perspectives."J Gastroenterol. (in press). (2004)
Kudo M:“肝细胞癌的局部消融治疗:现状和未来前景。”J Gastroenterol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kudo M, Minami Y: "Raiofrequency ablation therapy under harmonic imaging guidance for the recurring cancer after local therapy for HCC : a randomized controlled study with RFA under B-mode guidance."Ultrasound Med Biol. 29. 145 (2003)
Kudo M、Minami Y:“谐波成像指导下的射频消融治疗 HCC 局部治疗后复发的癌症:B 模式指导下 RFA 的随机对照研究。”超声医学生物学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
113
    Effect of tyrosine kinase inhibitor for immunological microenviroment of hepatocellular carcinoma
    • 批准号:
      18K07922
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2018
    • 负责人:
      KUDO Masatoshi
    • 依托单位:
    Development of biomarker for sorafenib treatment using serum microRNA in patients with hepatocellular carcinoma
    • 批准号:
      15K09028
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2015
    • 负责人:
      KUDO Masatoshi
    • 依托单位:
    Moleculer mechanism of Hepatocarcinogenesis and Development : Combined Analysis with Kupffer phase Contrast-enchanced US and Gene Expression.
    • 批准号:
      23650312
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2010
    • 负责人:
      KUDO Masatoshi
    • 依托单位:
    Newly Developed Image Analysis Method of Tumor Blood Flow : Separate Quantitative Analysis of Intranodular Arterial and Portal Blood Flow and Its Application to Research on Hepatocarcinogenesis
    • 批准号:
      18300176
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.67万
    • 财政年份:
      2006
    • 负责人:
      KUDO Masatoshi
    • 依托单位:
    海外基金